Abstract:Background: Cancer-related cognitive dysfunction (CRCD) is a major functional disorder in patients with cancer. This central nervous dysfunction is found in up to 60 % of patients after tumour therapy, often significantly limits the quality of life and significantly impedes participation in working life. For this reason, diagnosis and treatment of CRCD is of central importance. This narrative review is intended to provide an overview and support for practical clinical care with regard to diagnostics and therapeutic options. Summary: In Germany, CRCD has received insufficient attention in clinical practice due to the lack of guidelines for diagnosis and therapy. The pathophysiology is complex and cannot be explained by chemotherapeutic treatment alone. In addition to the tumour disease as such and the tumour therapy, psychological factors such as anxiety and depression as well as sleep disorders also play a significant role. Today it is known that in addition to age, molecular genetic changes also have an effect on cognitive function. Morphologically, CRCD can be located in the frontal cortex and hippocampus. In addition to easy-to-use screening instruments such as the visual analogue scale (VAS), validated questionnaires such as the Questionnaire of Subjectively Experienced Deficits in Attention (FEDA) developed in Germany are also available. These allow the suspected diagnosis to be substantiated and the patient to be referred to further neurological, neuropsychological or psycho-oncological diagnostics. Within the framework of further neuropsychological diagnostics, the International Cognition and Cancer Task Force (ICCTF) recommends testing learning, memory, processing speed and executive functions. From the authors' point of view, a step-by-step diagnosis is recommended in order to avoid overdiagnosis. In clinical practice, graduation according to the "Common Terminology Criteria for Adversity Events" (CTCAE Version 5.0) is suitable for assessing the degree of severity. Cognitive training should be behaviourally oriented and include regular practice of cognitive skills to restore attention, psychomotor speed, memory and executive functions. The best evidence is currently found for web-based training programmes that can be used by the patient at home. There is also evidence for mindfulness training and physical exercises. In particular, the combination of these three therapeutic elements currently seems to be the optimal treatment strategy for CRCD. Key Messages: Cognitive dysfunction should be given much more attention in the clinical care of cancer patients. Diagnostic tools for this purpose and evidence-based therapeutic interventions are available. In the future, networks should be created that allow for better care of patients with CRCD.

Cognitive Dysfunction, Mood Disorders, and Fatigue as Complications of Cancer

Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management

A Narrative Review of Cancer-Related Fatigue (CRF) and Its Possible Pathogenesis

[Complementary and integrative medicine in cancer-related fatigue]

[Effect of Cancer Symptoms and Fatigue on Chemotherapy-related Cognitive Impairment and Depression in People with Gastrointestinal Cancer]

Fatigue and weakness in cancer patients: The symptom experience

Neurocognitive Dysfunction and Psychosocial Issues

Tumour brain: Pretreatment cognitive and affective disorders caused by peripheral cancers

Cancer-related cognitive impairment as a key contributor to psychopathology in cancer survivors: implications for prevention, treatment and supportive care

Long-Term Cognitive Dysfunction in Cancer Survivors

Assessment and Management of Cognitive Symptoms in Patients With Brain Tumors.

Cancer related cognitive dysfunction - A narrative review for clinical practice

Cognitive performance of breast cancer survivors in daily life: Role of fatigue and depressed mood

Neuropsychological Evaluation for Oncology

Depression in cancer patients: Pathogenesis, implications and treatment (Review)

Physiological and psychosocial correlates of cancer-related fatigue

My get up and go got up and went: fatigue in people with cancer

Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know?

Common Biological Pathways Underlying the Psychoneurological Symptom Cluster in Cancer Patients

The biology of cancer-related fatigue: a review of the literature

Prevalence and biopsychosocial indicators of fatigue in cancer patients